Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro.
Yan, Yan-Yan
Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro. [electronic resource] - Oncology reports Jan 2017 - 31-40 p. digital
Publication Type: Journal Article
1791-2431
10.3892/or.2016.5230 doi
ATP Binding Cassette Transporter, Subfamily B--genetics
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Cell Line, Tumor
Cells, Cultured
Doxorubicin--pharmacology
Drug Resistance, Multiple--drug effects
Drug Resistance, Neoplasm--drug effects
HEK293 Cells
Humans
Pentacyclic Triterpenes
Proteolysis--drug effects
Triterpenes--pharmacology
Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro. [electronic resource] - Oncology reports Jan 2017 - 31-40 p. digital
Publication Type: Journal Article
1791-2431
10.3892/or.2016.5230 doi
ATP Binding Cassette Transporter, Subfamily B--genetics
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Cell Line, Tumor
Cells, Cultured
Doxorubicin--pharmacology
Drug Resistance, Multiple--drug effects
Drug Resistance, Neoplasm--drug effects
HEK293 Cells
Humans
Pentacyclic Triterpenes
Proteolysis--drug effects
Triterpenes--pharmacology